Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis by Arbyn, M et al.
RESEARCH
Perinatal mortality and other severe adverse pregnancy
outcomes associated with treatment of cervical
intraepithelial neoplasia: meta-analysis
MA r b y n ,h e a do fu n i to fc a n c e re p i d e m i o l o g y
1, leader, working package HPV screening,
2
M Kyrgiou, assistant,
3 C Simoens, assistant,
1 AOR a i f u ,a s s i s t a n t ,
1 G Koliopoulos, senior lecturer,
4
P Martin-Hirsch, consultant gynaecological oncologist,
3 W Prendiville, associated professor,
5
E Paraskevaidis, head of department
4
ABSTRACT
ObjectiveToassesstherelativeriskofperinatalmortality,
severe preterm delivery, and low birth weight associated
with previous treatment for precursors of cervical cancer.
Data sources Medline and Embase citation tracking from
January 1960 to December 2007.
Selection criteria Eligible studies had data on severe
pregnancy outcomes for women with and without
previous treatment for cervical intraepithelial neoplasia.
Considered outcomes were perinatal mortality, severe
preterm delivery (<32/34 weeks), extreme preterm
delivery (<28/30 weeks), and low birth weight (<2000 g,
<1500 g, and <1000 g). Excisional and ablative treatment
procedures were distinguished.
ResultsOneprospectivecohortand19retrospectivestudies
were retrieved. Cold knife conisation was associated with a
significantlyincreasedriskofperinatalmortality(relativerisk
2.87, 95% confidence interval 1.42 to 5.81) and a
significantlyhigherriskofseverepretermdelivery(2.78,1.72
to4.51),extremepretermdelivery(5.33,1.63to17.40),and
low birth weight of <2000 g (2.86, 1.37 to 5.97). Laser
conisation,describedinonlyonestudy,wasalsofollowedby
asignificantlyincreasedchanceoflowbirthweightof<2000g
and <1500 g. Large loop excision of the transformation zone
and ablative treatment with cryotherapy or laser were not
associated with a significantly increased risk of serious
adverse pregnancy outcomes. Ablation by radical diathermy
was associated with a significantly higher frequency of
perinatalmortality,severeandextremepretermdelivery,and
low birth weight below 2000 g or 1500 g.
Conclusions In the treatment of cervical intraepithelial
neoplasia, cold knife conisation and probably both laser
conisation and radical diathermy are associated with an
increased risk of subsequent perinatal mortality and other
serious pregnancy outcomes, unlike laser ablation and
cryotherapy.Largeloopexcisionofthetransformationzone
cannot be considered as completely free of adverse
outcomes.
INTRODUCTION
Wellorganisedcervicalscreeningprogrammesandthe
appropriate management of screen detected
intraepithelial lesions have reduced the incidence of
cervical cancer by up to 80%.
1 Large loop excision of
the transformation zone, also known as loop electro-
surgical excision, has become the standard treatment
forwomenwithcervicalprecancerintheindustrialised
world.
2-5Largeloopexcisionhassimilarfailureratesto
other treatment methods
6 but has become the treat-
ment of choice because of other clinical advantages,
including the ability to examine the margins of the
extirpated transformation zone and thereby assess the
completeness of excision, the precise histological
diagnosis, and the presence of unexpected glandular
or microinvasive disease. The ability to combine
diagnosis and treatment in one visit and its low
morbidity have also influenced practice.
7-9 Adverse
obstetric outcomes after cold knife conisation have
been reported.
1011 w1-w3 Divergent conclusions were
drawn regarding the obstetric outcomes for the other
excisional treatment procedures,
1213 w4-w7 whereas
ablativemethodssuchaslaserablationorcryotherapy,
which destroycervical tissue, are believed to be free of
adverse obstetric risk.
14 w8 w9
Asthe incidence ofcervical intraepithelial neoplasia
requiringtreatment(that is, gradeII or worse)peaks at
around the age of 30, any possible effects of such
treatment on future childbearing are of particular
importance.
15 In a recent meta-analysis, Kyrgiou et al
evaluated a limited number of pregnancy outcomes in
women previously treated for cervical intraepithelial
neoplasia.
16Thispooledanalysisreportedthattherisks
for preterm delivery among women treated with large
loop excision of the transformation zone or cold knife
conisationwere1.7(95%confidenceinterval1.2to2.4)
and 2.6 (1.8 to 3.7) times higher than in untreated
women. A significantly increased risk was also noted
for low birth weight after both these procedures, for
premature rupture of membranes after large loop
excision, and for caesarean delivery after cold knife
conisation. Preterm delivery, low birth weight, and
premature rupture were more common after laser
conisation but the differences were insignificant. Laser
ablation was not associated with adverse obstetric
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ment procedures might be associated with adverse
pregnancy outcomes.
The publication of Kyrgiou et al’s meta-analysis has
been followed by two small studies
w10 w11 and four
involving large populations.
w12-w15 This new informa-
tion,togetherwithdatareceiveddirectlyfromauthors,
now allows a new more comprehensive systematic
review and meta-analysis with a focus on more serious
outcomes like delivery before 32 weeks, birth weight
under 2000 g, and perinatal mortality that previous
reviews have not been able to analyse.
METHODS
Studies and interventions, inclusion and exclusion criteria
We included studies with data on severe obstetric or
neonatal outcomes in women treated for cervical
intraepithelial neoplasia and in a control group of
untreated women. Two types of treatment were
considered: excisional procedures (cold knife conisa-
tion, large loop excision of the transformation zone,
and laser conisation) and ablative procedures (laser
ablation, cryotherapy, and diathermy).
Outcome measures
The severe adverse obstetric or neonatal events were
perinatal mortality, severe (at less than 32/34 weeks’
gestation) and extreme (<28/30 weeks) preterm
delivery, and severe low birth weight (<2000 g,
<1500 g, and <1000 g).
Retrieval of studies and data extraction
Eligible studies published between 1960 and Novem-
ber 2007 were retrieved through a PubMed-Medline
and Embase search with the keywords: cervical intra-
epithelial neoplasia, CIN, cervical cancer, LLETZ,
large loop excision of the transformation zone, LEEP,
loop electrosurgical excision procedure, cold knife
conisation, laser ablation, laser vaporisation, laser
conisation, laser excision, pregnancy outcomes, peri-
natalmortality,pretermdelivery,andlowbirthweight.
We also hand searched references of the retrieved
articlesandtheproceedingsoftherelevantconferences
to identify any articles missed by the initial search and
any unpublished data. There was no language restric-
tion. Three authors (MA, MK, and CS) verified
Cold knife conisation 
  Jones 1979w1
  Larsson 1982w2
  Kuoppala 1986w24*
  Lund 1986w25
  Crane 2006w11*
  Bruinsma 2007w13
  Jakobsson 2007w14
Subtotal (I
2=17.0%, P=0.300)
Laser conisation 
  Bekassy 1996w27
  Formso 1996w8
  Andersen 1999w28†
Large loop excision of transformation zone 
  Blomfield 1993w5
  Braet 1994w6*
  Acharya 2005w10
  Samson 2005w4*
  Crane 2006w11
  Bruinsma 2007w13*
  Jakobssen 2007w14
Subtotal (I
2=0.0%, P=0.862)
Excision (not otherwise specified)
  Jakobsson 2007w14
  Sjoborg 2007w15
Subtotal (I2=0.0%, P=0.892)
2.67 (0.45 to 15.64)
1.44 (0.47 to 4.40)
5.00 (0.24 to 102.07)
11.35 (2.68 to 48.10)
1.29 (0.05 to 30.44)
0.90 (0.12 to 6.46)
4.23 (1.07 to 16.66)
2.87 (1.42 to 5.81)
0.67 (0.11 to 3.96)
8.00 (0.91 to 70.14)
Excluded
2.00 (0.13 to 31.15)
3.00 (0.12 to 72.53)
2.00 (0.13 to 31.56)
7.00 (0.36 to 135.21)
1.08 (0.07 to 16.97)
0.46 (0.03 to 7.45)
1.08 (0.65 to 1.80)
1.17 (0.74 to 1.87)
2.68 (1.87 to 3.86)
3.00 (0.61 to 14.82)
2.70 (1.89 to 3.85)
2/66
6/197
2/62
20/251
0/20
1/73
2/92
33/761
2/250
4/65
0/75
1/40
1/78
1/79
3/571
1/74
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15/2690
22/3601
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36/2806
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2258/439 116
2305/442 385
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1/130
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1/80
0/78
1/158
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1/80
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2258/439 116
2296/442 377
636/117 429
2/742
638/118 171
Events,
not treated
4.02
8.59
1.49
5.70
1.36
3.30
6.21
30.66
3.97
2.77
0.00
1.79
1.34
1.77
1.55
1.78
1.74
21.44
31.41
26.39
4.80
31.19
Weight
(%)
Fig1 |Meta-analysisofrelativeriskofperinatalmortalityassociatedwithexcisionaltreatmentforcervicalintraepithelialneoplasia.
*0.5addedtoeachcellof2×2contingencytablebecausenocaseswerefoundinoneofcomparisongroups.†Excludedbecauseno
events in both groups. In subtotals relative risks are pooled by treatment procedure (only computed in absence of significant
heterogeneity between studies)
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Study design Procedure
Pregnancy
outcome
Study size
Inclusion/exclusion criteria Control of confounding factors Treated Untreated
Jones, 1979
w1 (UK) Retrospective
matched cohort
CKC PM 66 264 Onlysingletonpregnancies,gestation>
28 weeks
Matching for age, parity, social class,
date of delivery
Larsson, 1982
w2 (Sweden) Retrospective
matched cohort
CKC PM 197 284 PD and late spontaneous abortions
due to known factors (uterus bicornis,
placenta previa) excluded
Self matching (comparison before and
after conisation)
Ludviksson, 1982
w3
(Sweden)
Retrospective
matched cohort
CKC PD <34 weeks,
<30 weeks
83 79 Age <35 years Matchingforage,parity,dateofdelivery
Kuoppala, 1986
w24
(Finland)
Retrospective
matched cohort
CKC PM 62 62 Age <40 years Matchingforage,parity,dateofdelivery
Lund, 1986
w25 (Norway) Retrospective
matched registry
based cohort
CKC PM, PD
≤28 weeks,
LBW <1000 g
251 285 Women born in1950-4 and pregnancy
outcomes 1967-81
Matchingforage,periodofdelivery,and
self matching (comparison before and
after conisation)
Blomfield, 1993
w5 (UK) Retrospective
matched cohort
LLETZ PM 40 80 Only singleton pregnancies Matching for age, parity, ethnic group,
date of delivery
Braet, 1994
w6 (UK) Retrospective
matched cohort
LLETZ PM 78 78 Only first singleton viable pregnancies Matching for age, parity, smoking, date
of delivery
Cruickshank, 1995
w7 (UK) Retrospective
matched cohort
LLETZ PD <28 weeks 149 298 Only first singleton pregnancies.
Gestation ≥20 weeks
Matching for age, parity, smoking,
height, social class
Sagot, 1995
w29 (France) Retrospective
matched cohort
LC PD <32 weeks 53 59 Non-spontaneous PD excluded Self matching (comparison before and
after conisation)
Bekassy, 1996
w27
(Sweden)
Retrospective
matched cohort
LC (mini-
conisation)
PM 250 250 Gestation ≥28 weeks Matchingforage,parity,dateofdelivery
Forsmo, 1996
w8 (Norway) Retrospective
matched cohort
LC, LA PM, LBW
<2000 g,
<1500 g
LC65, LA
22
LC 130, LA
44
Only singleton pregnancies Matching for age, parity, place of
delivery
Andersen, 1999
w28
(Denmark)
Retrospective
matched cohort
LC PM 75 150 Gestation >27 weeks Matchingforage,parity,date,andplace
of delivery. Other factors (social class,
smoking) controlled by logistic
regression
El-Bastawissi, 1999
w30
(US)
Retrospective
population based
cohort
CKC/LLETZ PD <34 weeks,
<28 weeks
974 7975 Only singleton pregnancies Frequency matching for age, country of
birth.Adjustedforsmoking,race,parity,
marital status, history of pregnancy
termination, by logistic regression
Van Rooijen, 1999
w9
(Sweden)
Retrospective
matched cohort
LA LBW <2000 g 236 472 Age <35 years Matchingforage,parity,dateofdelivery
Acharya,2005
w10 (Norway) Retrospective
matched cohort
LLETZ PM 79 158 Age <45 years, gestation >20 weeks,
only first pregnancies. Ectopic
pregnancies excluded
Matching for age, parity, smoking, date
of delivery, previous obstetric history
Samson, 2005
w4 (Canada) Retrospective
matched cohort
LLETZ PM, PD
<34 weeks
571 571 Age <45 years, gestation >20 weeks,
only first pregnancies
Matching for age, parity, smoking, and
date and place of delivery
Crane, 2006
w11 (Canada) Prospective cohort CKC, LLETZ,
CT
PM, PD
<34 weeks
CKC 21,
LLETZ
75,
CT 36
81 Only singleton pregnancies. Women
withknownriskfactorsforPD(previous
PD, PD for maternal or fetal reasons)
excluded
Adjustment for age, parity, smoking,
third trimester bleeding by logistic
regression
Klaritsch,2006
w12(Austria) Retrospective
service registry
based cohort
CKC PD <34 weeks 76 29 686 Only singleton deliveries. Women with
repeated CIN treatments excluded
None
Bruinsma, 2007
w13
(Australia)
Retrospective
population based
cohort
CKC, LLETZ,
DT, LA
PM, PD
<32 weeks,
<28 weeks,
LBW <1500 g,
<1000 g
CKC 73,
LLETZ
69, DT
773, LA
1016
2294 Gestation ≥20 weeks or >400 g Obstetric antecedents, illicit drug use
during pregnancy, major maternal
medicalcondition,birthatstudycentre,
being single,age,referral cytology were
significant covariates in logistic
regression model for PD. Parity and
country of birth were insignificant
Jakobsson, 2007
w14
(Finland)*
Retrospective
population based
cohort
CKC, LLETZ,
excision, CT,
LA
PM, PD
<32 weeks,
<28 weeks
CKC 92,
LLETZ
2690,
excision
2064, CT
644, LA
1349
1997-2004:
439 116;
1984-96:
117 429
Age 15-49 years. Only singleton
pregnancies
Age, parity, smoking were adjusted for
by logistic regression
Sjoborg, 2007
w15 (Norway) Retrospective
matched cohort
LC/LLETZ PM, PD
<32 weeks,
<28 weeks,
LBW <1500 g,
<1000 g
742 742 Age ≤40 years, gestation ≥16 weeks Matched for age, parity, plurality.
Adjustment for smoking, SE status by
logistic regression
CKC=cold knife conisation; LC=laser conisation; LLETZ=large loop excision of transformation zone; excision (NOS)=excision (not otherwise specified); CT=cryotherapy; DT=diathermy; LA=laser
ablation; PM=perinatal mortality; LBW=low birth weight; PD=preterm delivery; SE=socioeconomic; CIN=cervical intraepithelial neoplasia.
*For period 1997-2004 data stratified by treatment procedure were obtained from authors; for period 1984-96 only distinction ablative or excisional treatment was available.
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reached consensus in case of discordance.
Studieswereclassifiedaccordingtotypeoftreatment
(excisionalorablative)andbyspecifictreatment.From
every included study we extracted or computed the
total number of pregnant women treated and not
treated for cervical intraepithelial neoplasia and the
numberofadverseobstetricorneonataleventsinboth
groups. We contacted authors to obtain data on
outcomes by particular treatment procedure if they
were not provided in the original reports. In addition,
we collected data on the study design and matching
criteria applied for the selection of a control group of
non-treated women.
Statistical analysis
We calculated the relative risks for each adverse
pregnancy outcome in the treated versus untreated
women. Studies were separated by type of treatment
andfurthergroupedby treatmentprocedure.Weused
a random effects model to pool relative risks.
17 In
studies with no events in the treated or control group,
we added 0.5 to each cell of the contingency table
(continuity correction) to allow calculation of relative
risk.Weexcludedstudieswithnoeventsinbothgroups
from the meta-analysis. We assessed heterogeneity
between studies with Cochrane’s Q test and evaluated
the percentage of total variation across studies caused
by heterogeneity with I
2.
1819 The relative risks for
severe adverse pregnancy outcomes were not pooled
when there was evidence of significant heterogeneity
between studies (P<0.10). In the absence of hetero-
geneity between groups we computed overall relative
risks by weighting the counts of the control group
according to the size of the corresponding treated
groups for studies that contributed data for multiple
procedures.
As severe obstetric outcomes are rare (for instance,
the incidence of preterm delivery is less than 1% and
severalstudieshavenoeventsinoneofthecomparison
groups), the pooled relative risks can be unstable and
influenced by the chosen continuity correction and
pooling method.
20 To test robustness, we applied
several alternative methods for pooling (fixed and
random effect models, Poisson regression with study
population as an offset), weighting of the study
estimates (Mantel-Haenszel, reciprocal of the var-
iance), and continuity correction values.
1721-23
Finally,wepooledtheabsolutefrequencyofadverse
outcomes after treatment (pT) and in the cumulated
control populations (pC) and derived the number
needed to treat to harm (NNTH) as the reciprocal of
theriskdifference(1/[pT−pC]).TheNNTHreflectsthe
number of women who need to undergo treatment to
result in one adverse obstetric event because of the
treatment.
24
We used Stata/SE 9.2 for Windows (StataCorp,
College Station, TX) for statistical analysis.
RESULTS
Inclusion of studies
We identified seven studies providing information on
pregnancy outcomes in women treated for cervical
intraepithelial neoplasia that we subsequently
excluded as they presented no data on a non-treated
control group.
w16-w22 One further study investigating
laser treatment (laser conisation and laser ablation)
was excluded as the authors did not provide outcome
data for the excisional or the ablative treatment
separately.
w23
Cryotherapy
  Crane 2006w11*
  Jakobsson 2007w14
Subtotal (I
2=0.0%, P=0.914)
Diathermy
  Bruinsma 2007w13
Laser ablation
  Bruinsma 2007w13
  Jakobsson 2007w14
  Formso 1996w8†
Subtotal (I2=0.0%, P=0.579)
Overall (I
2=22.5%, P=0.271)
0.73 (0.03 to 17.49)
0.60 (0.15 to 2.41)
0.62 (0.17 to 2.22)
1.54 (0.84 to 2.82)
0.51 (0.20 to 1.25)
0.72 (0.30 to 1.73)
Excluded
0.61 (0.32 to 1.14)
0.87 (0.53 to 1.45)
0/36
2/644
2/680
18/773
8/1016
5/1349
0/22
13/2387
33/3840
0.01 0.1 0.5 1 2 10 100
Study
Favours
treatment
Favours
control
Risk ratio
(95% CI)
Risk ratio
(95% CI)
Events,
treated
1/80
730/141 892
731/141 972
24/1588
11/706
1528/297 224
0/44
1539/297 974
2294/441 534
Events,
not treated
2.46
11.54
14.00
38.90
22.98
24.12
0.00
47.10
100.00
Weight
(%)
Fig 2 | Meta-analysis of relative risk of perinatal mortality associated with ablative treatment for cervical intraepithelial neoplasia.
*0.5 added to each cell of 2×2 contingency table because no cases found in one comparison group, allowing computation of
relative risk. †Excluded because no events in both groups. To compute overall relative risk, counts of control groups in reports
by Bruinsma
w13 and Jakobsson
w14 were weighted proportionally to size of corresponding treated groups to avoid double counting
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criteria and provided data on perinatal mortality.
w1 w2
w4-w6 w8 w10 w11 w13-w15 w24-w28 The number of studies that
evaluated the other severe pregnancy outcomes was
smaller:11studiesreportedonpretermdeliverybefore
34 weeks of gestation
w13 w4 w7 w11-w15 w25 w29 w30 and five
studies on birth weight <2000 g.
w8 w9 w13 w15 w25 Two
studies involved only women treated for carcinoma in
situ,
w25 w30 while the rest included varying degrees of
cervical intraepithelial neoplasia. For two of those
reports, the original papers did not provide data on
procedure specific outcomes, which were obtained
directly from the authors.
w13 w14 For the study by
Jakobsson et al procedure specific outcomes were
available only for the period 1997-2004.
w14 We found
eight new studies that were not included in the meta-
analysis of Kyrgiou et al
16: six newer reports
w10-w15 and
two older references identified by more comprehen-
sive literature retrieval.
w25 w28 Reports were written in
English, except one that was in Norwegian.
w25
Study characteristics
Table 1describesthecharacteristicsofincludedstudies
rankedbyyearofpublication.Womenweretreatedby
cold knife conisation in nine studies,
w1-w3 w11-w14 w24 w25
large loop excision of the transformation zone in eight
studies,
w4-w7 w10 w11 w13 w14 and laser conisation in four
studies.
w8 w27-w29 In three studies, women were treated
with excision biopsies without further clarification of
the specific treatment.
w14 w15 w30 Pregnancy outcomes
after ablative treatment were less often described: two
reports after cryotherapy,
w11 w14 four after laser abla-
tion,
w8 w9 w13 w14 and only one after diathermy.
w13
Most included studies concerned retrospective
cohorts; only one included a prospective cohort.
w11
w25 In five studies, the control group comprised all
women without a history of treatment included in
national, regional, or service based birth registries.
w12-
w14 w30Threestudiescomparedpregnancyoutcomesin
thesamegroupofwomenbeforeandaftertreatment.
w2
w25 w29 The other studies selected a control population
after matching each treated woman with one to four
untreated ones for several potential confounding
factors such as age, parity, period of birth, smoking
status,socioeconomicstatus,andobstetricantecedents
(table 1).
Perinatal mortality
Figure1showsthevariationinrelativeriskforperinatal
mortality associated with excision of cervical intra-
epithelialneoplasia.Thisforestplotcontainssubgroup
meta-analyses by treatment procedure. Because of
significant heterogeneity between procedures
(P=0.031), we have not shown an overall pooled
relative risk.
The risk of perinatal mortality was significantly
increased in women treated with cold knife conisation
(relative risk 2.87, 95% confidence interval 1.42 to
5.81). The Norwegian study showed an outlying high
relativeriskof11.35(2.68to48.10).
w25Omissionofthis
study still yielded a pooled relative risk that was
significantly different from unity (2.08, 1.04 to 4.13).
The risk associated with laser conisation was
heterogeneous (I
2=67%, P=0.082) and therefore not
pooled. One study in which mini-conisation was used
showed no increase (0.67, 0.11 to 3.96)
w27 and another
showed a substantial increase but did not reach
significance (8.00, 0.91 to 70.14).
w8
Four of seven studies showed a non-significantly
increased risk of perinatal mortality in women treated
Table 2 |Meta-analysisofstudiescomparingoutcomeofseverepretermdelivery(<32/34
weeks)accordingtotreatmentforcervicalintraepithelialneoplasia
No (%) of women
Relative risk (95% CI) Treated Not treated
Excisional treatment
Cold knife conisation
Ludviksson, 1982
w3*
(<34 weeks)
3/83 (3.6) 0/79 (0.0) 6.67 (0.35 to 127.03)
Crane, 2006
w11*
(<34 weeks)
0/21 (0.0) 1/81 (1.2) 1.24 (0.05 to 29.46)
Klaritsch, 2006
w12
(<34 weeks)
7/76 (9.2) 871/29 686 (2.9) 3.14 (1.55 to 6.38)
Bruinsma, 2007
w13
(<32 weeks)
4/71 (5.6) 43/2181 (2.0) 2.86 (1.05 to 7.74)
Jakobsson, 2007
w14
(<32 weeks)
4/92 (4.3) 9542/469 713 (2.0) 2.14 (0.82 to 5.58)
Pooled 18/343 (4.6) 10 457/501 740 (1.6) 2.78 (1.72 to 4.51),
P=0.911 (I
2=0.0%)
Laser conisation
Sagot, 1995
w29*
(<32 weeks)
1/53 (1.9) 0/59 (0.0) 3.33 (0.73 to 16.77)
Large loop excision of transformation zone
Samson, 2005
w4
(<34 weeks)
7/558 (1.3) 2/558 (0.4) 3.50 (0.73 to 16.77)
Crane,2006
w11(<34weeks) 3/75 (4.0) 1/81 (1.2) 3.24 (0.34 to 30.47)
Bruinsma, 2007
w13
(<32 weeks)
1/69 (1.4) 43/2181 (2.0) 0.74 (0.10 to 5.26)
Jakobsson, 2007
w14
(<32 weeks)
40/2690 (1.5) 9542/469 713 (2.0) 0.73 (0.54 to 1.00)
Pooled 51/3392 (2.0) 9588/472 533 (1.4) 1.20 (0.50 to 2.89),
P=0.156 (I
2=42.7%)
Excision (not otherwise specified)
El-Bastawissi, 1999
w30
(<34 weeks)
44/974 (4.5) 169/7975 (2.1) 2.13 (1.54 to 2.95)
Sjoborg, 2007
w15
(<32 weeks)
25/742 (3.4) 6/742 (0.8) 4.17 (1.72 to 10.10)
Pooled 69/1716 (4.0) 175/8717 (1.5) 2.63 (1.41 to 4.89),
P=0.154 (I
2=50.7%)
Ablative treatment
Cryotherapy
Crane,2006
w11(<34weeks) 1/36 (2.8) 1/81 (1.2) 2.25 (0.14 to 34.98)
Jakobsson, 2007
w14
(<32 weeks)
11/644 (1.7) 9542/469 713 (2.0) 0.84 (0.47 to 1.51)
Pooled 12/680 (2.2) 9543/469 794 (1.6) 0.88 (0.49 to 1.56),
P=0.492 (I
2=0.0%)
Diathermy
Bruinsma, 2007
w13
(<32 weeks)
38/760 (5.0) 43/2181 (2.0) 2.54 (1.65 to 3.89)
Laser ablation
Bruinsma, 2007
w13
(<32 weeks)
23/1005 (2.3) 43/2181 (2.0) 1.16 (0.70 to 1.92)
Jakobsson, 2007
w14
(<32 weeks)
8/1349 (0.6) 9542/469 713 (2.0) 0.29 (0.15 to 0.58)
*Studies with continuity correction k=0.05.
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w4-
w6 w10whereasinthreetherelativeriskwasneartoornot
significantly lower than unity.
w11 w13 w14 This yielded a
pooled relative risk of 1.17 (0.74 to 1.87).
Womenwhosecervicalintraepithelialneoplasiawas
treated by excision without specification of the
procedure showed a significantly increased risk of
perinatal mortality.
Although the risk associated with ablative treatment
was not increased (fig 2), there was a tendency for
increased perinatal mortality in women treated with
diathermy (relative risk 1.54, 0.84 to 2.82).
Severe and extreme preterm delivery
Severe preterm delivery(gestation <32/34 weeks) was
significantly more common after cold knife conisation
(pooled relative risk 2.78, 1.72 to 4.51) (table 2).
InasmallFrenchstudy,onecaseofpretermdelivery
at less then 32 weeks was observed in 53 women who
became pregnantaftertreatmentwith laserconisation,
whereas none was observed in pregnancies before
treatment.
w29
Treatment with large loop excision of the transfor-
mation zone was not associated with an increased risk
of severe preterm delivery (relative risk 1.20, 0.50 to
2.89) and showed heterogeneous results regarding
extreme preterm delivery (table 3).
In two studies that used cold knife conisation or
another excisional procedure without distinction by
procedure, relative risks for severe
w15 w30 and extreme
preterm delivery
w15 were significantly increased. El-
Bastawissietalusedcoldknifeconisationorlargeloop
excision and observed a relative risk for preterm
delivery at <34 weeks of 2.13 (1.54 to 2.95),
w30 which
was intermediate to the pooled relative risks for cold
knifeconisation(2.78)andlargeloopexcision(1.20).In
the other study the relative risks for preterm delivery
were 4.17 (1.72 to 10.10) at <32 weeks (table 2) and
13.00 (1.70 to 99.12) <28 weeks (table 3).
w15
Laser ablation or cryotherapy was not associated
with higher rates of severe or extreme preterm
delivery: relative risks generally were lower but not
significantly lower than unity. In one study laser
ablation was associated with a significantly lower
probability of severe and extreme preterm delivery
withrelativerisksof0.29(0.15to0.58)and0.27(0.09to
0.82), respectively.
w14
In one study diathermy resulted in significantly
increasedratesofbothsevere(relativerisk2.54,1.65to
3.89) and extreme (relative risk 2.15, 1.11 to 4.18)
preterm delivery.
w13
Severe and extreme low birth weight
Tables 4, 5, and 6 show the effects on birth weight.
Threestudiesthatevaluatedcoldknifeconisation,laser
conisation,orexcisionwithlaserconisation/largeloop
excision showed a significantly increased risk for birth
weights <1500 g
w8 w13 w15 (table 5). In two Norwegian
studies cold knife conisation and excisional treatment
(with laser conisation/large loop excision) were asso-
ciated with extreme low birth weight (<1000 g,
table 6).
w15 w25
Laser ablation was not associated with increased
risks for very low birth weight (table 6), while a
significantly higher rate of birth weights of <2000 g
(table 4)and<1500g(table 5)wasobservedinwomen
treated with diathermy.
w13
Robustness of pooled relative risks
Treatment of cervical intraepithelial neoplasia with
large loop excision resulted in a non-significantly
increasedriskofperinatalmortality(1.17,0.74to1.87)
(fig1).Threeofthesevenstudies,however,showedno
counts in one of the comparison groups,
w4 w6 w13
necessitating the use of a continuity correction
(κ=0.5).Table 7showstheresultsofalternativemodels
for combining relative risks and different continuity
corrections. All models and continuity corrections
resulted in similar pooled estimates, underlying the
robustnessofthemeta-analysis.Similarpooledrelative
risks for perinatal mortality were also obtained for the
otherexcisionalmethods(dataavailablefromauthors).
Too few studies evaluating other outcomes were
availabletotesttherobustnessofthepooledestimates.
Obstetric harm after treatment
Wepooledthe absolutefrequencyofadverseobstetric
outcomes after treatment (pT) and in the cumulated
control populations (pC) and derived the number
neededtotreattoobserveobstetricharminonetreated
woman (NNTH) (table 8). We excluded the study of
Lund et al
w25 because of outlying relative risks that we
Table 3 |Meta-analysisofstudiescomparingoutcomeofextremepretermdelivery(<28/30
weeks)accordingtotreatmentforcervicalintraepithelialneoplasia
Study*
No (%) of women
Relative risk (95% CI) Treated Not treated
Excisional treatment
Cold knife conisation
Ludviksson, 1982
w3† 1/83 (1.2) 0/79 (0.0) 2.86 (0.12 to 69.11)
Lund, 1986
w25 23/233 (9.8) 1/273 (0.4) 26.95 (3.67 to 198.03)
Bruinsma, 2007
w13 3/71 (4.2) 20/2,181 (0.9) 4.61 (1.40 to 15.15)
Jakobsson, 2007
w14 2/92 (2.2) 3938/469 713 (0.8) 2.59 (0.66 to 10.22)
Pooled 29/479 (4.2) 3959/472 246 (0.8) 5.33 (1.63 to 17.40),
P=0.130 (I
2=46.9%)
Large loop excision of transformation zone
Cruickshank, 1995
w7 4/149 (2.7) 3/298 (1.0) 2.67 (0.60 to 11.76)
Bruinsma, 2007
w13† 0/69 (0.0) 20/2181 (0.9) 0.76 (0.05 to 12.44)
Jakobsson, 2007
w14 10/2690 (0.4) 3938/469 713 (0.8) 0.44 (0.24 to 0.82)
Excision (not otherwise specified)
Sjoborg, 2007
w15 13/742 (1.8) 1/742 (0.1) 13.00 (1.70 to 99.12)
Ablative treatment
Cryotherapy
Jakobsson, 2007
w14 4/644 (0.6) 3938/469 713 (0.8) 0.74 (0.28 to 1.97)
Diathermy
Bruinsma, 2007
w13 15/760 (2.0) 20/2181 (0.9) 2.15 (1.11 to 4.18)
Laser ablation
Bruinsma, 2007
w13 11/1005 (1.1) 20/2181 (0.9) 1.19 (0.57 to 2.48)
Jakobsson, 2007
w14 3/1349 (0.2) 3938/469 713 (0.8) 0.27 (0.09 to 0.82)
*All <28 weeks except for Ludviksson,
w3 which was <30 weeks.
†Studies with continuity correction k=0.05.
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studies.
Weestimatedthatprevioustreatmentwithcoldknife
conisation, laser conisation, or diathermy would result
in about one perinatal death in every 70 pregnancies.
After large loop excision of the transformation zone,
however,weestimateonlytwoperinataldeathsin1000
pregnancies.Severeandextremepretermdeliveryand
low birth weight were common (NNTH often <60)
aftercoldknifeconisationanddiathermybutrareafter
large loop excision (NNTH (delivery <32-34 weeks,
birth weight <2000 g) >100 or NNTH (birth weight
<1500 g) >500).
DISCUSSION
The current meta-analysis shows that, among all the
excisional methods used in the treatment of cervical
intraepithelial neoplasia, cold knife conisation is
consistentlyassociatedwithseriousadversepregnancy
outcomes. Laser conisation increased the risk of
perinatal mortality and very low birthweight infants
when we excluded from the analysis one study that
modified the technique and excised a substantially
smaller amount of tissue.
w27
Several new studies and reviews have recently been
published on outcomes of pregnancy after treatment
for cervical intraepithelial neoplasia.
w12-w15 25-27 These
newdataincreasedthesamplesizeandstatisticalpower
and enabled us, for the first time, to address the rarer
andmoreseriousoutcomessuchasperinatalmortality,
severeandextremepretermdelivery(<28weeks),and
verylowbirthweight(<2000g).Theseoutcomeshave
a considerable impact not only on the mothers and
babies concerned but also on the health budget for
neonatal intensive care.
The studies included in the earlier meta-analysis of
Kyrgiou et al revealed an increased risk for preterm
delivery and low birth weight associated with large
loop excision,
16 but in our meta-analysis we found that
it did not significantly affect the more serious adverse
obstetric events. Both meta-analyses corroborate the
conclusion that ablation with laser has no effects on
obstetricoutcomes.TherecentstudybyJakobssonetal
reportedsimilarfindingsforcryotherapy.
w14Bruinsma
et al reported that radical diathermy, an aggressive
ablativemethodthatdestroystissuetoadepthofabout
1 cm, was associated with perinatal mortality, extreme
preterm delivery, and severe low birth weight, which
was of the same order of magnitude as seen with
treatment with cold knife conisation.
w13 The signifi-
cantlydecreasedriskofseriouspregnancyoutcomesin
women treated by laser ablation in the study of
Jakobsson et al,
w14 is probably because of the prefer-
ential use of this procedure in Finland for women with
small or less severe lesions and at low risk of preterm
delivery (P Nieminen, personal communication,
2008).
Biological mechanisms
Removal or destruction of part of the cervix might
compromiseitsfunction,leadingtolackofmechanical
support in a future pregnancy and subsequent pre-
matureruptureofmembranesandpretermdelivery.A
reasonable hypothesis would be that the degree of
obstetric morbidity noted between therapeutic proce-
dures might be related to the amount of the cervical
tissueremovedordestroyed,whichislesspronounced
with ablative techniques such as laser ablation and
cryotherapy. Several investigators have described a
positiveassociationbetweendepthofexcisionandrisk
of adverse obstetric events.
w4 28-30 The proportion of
the total cervical volume or endocervical canal
removed might be more important than the actual
depth of excision. Inevitably, the knife excises, on
average,moretissuethantheloop,whileloopexcisions
might vary considerably from superficial and low
Table 4 |Meta-analysisofstudiescomparingoutcomeofseverelowbirthweight(<2000g)
accordingtotreatmentforcervicalintraepithelialneoplasia
Study
No (%) of women
Relative risk (95% CI) Treated Not treated
Excisional treatment
Cold knife conisation
Bruinsma, 2007
w13 7/73 (9.6) 77/2293 (3.4) 2.86 (1.37 to 5.97)
Laser conisation
Forsmo, 1996
w8 7/65 (10.8) 4/130 (3.1) 3.50 (1.06 to 11.53)
Large loop excision of transformation zone
Bruinsma, 2007
w13 3/69 (4.3) 77/2293 (3.4) 1.29 (0.42 to 4.00)
Pooled excisional 17/207 (8.2) 158/4716 (3.4) 2.47 (1.43 to 4.28), P=0.418 (I
2=0.0%)
Ablative treatment
Diathermy
Bruinsma, 2007
w13 53/773 (6.9) 77/2293 (3.4) 2.04 (1.45 to 2.87)
Laser ablation
Forsmo, 1996
w8 1/22 (4.5) 2/44 (4.5) 1.00 (0.10 to 10.44)
Van Rooijen, 1999
w9 6/236 (2.5) 13/472 (2.8) 0.92 (0.36 to 2.40)
Bruinsma, 2007
w13 35/1016 (3.4) 77/2293 (3.4) 1.03 (0.69 to 1.52)
Pooled laser ablation 42/773 (3.4) 92/2809 (3.6) 1.01 (0.71 to 1.45), P=0.980 (I
2=0.0%)
Table 5 |Meta-analysisofstudiescomparingoutcomeofseverelowbirthweight(<1500g)
accordingtotreatmentforcervicalintraepithelialneoplasia
Study
No (%) of women
Relative risk (95% CI) Treated Not treated
Excisional treatment
Cold knife conisation
Bruinsma, 2007
w13 3/73 (4.1) 41/2293 (1.8) 2.30 (0.73 to 7.25)
Laser conisation
Forsmo, 1996
w8 5/65 (7.7) 1/130 (0.8) 10.00 (1.19 to 83.84)
Large loop excision of transformation zone
Bruinsma, 2007
w13 1/69 (1.4) 41/2293 (1.8) 0.81 (0.11 to 5.81)
Excision (not otherwise specified)
Sjoborg, 2007
w15 17/742 (2.3) 4/742 (0.5) 4.25 (1.44 to 12.57)
Pooled excisional 26/949 (3.9) 87/5458 (1.2) 3.01 (1.38 to 6.56), P=0.311
(I
2=16.1%)
Ablative treatment
Diathermy
Bruinsma, 2007
w13 35/773 (4.5) 41/2293 (1.8) 2.53 (1.62 to 3.95)
Laser ablation
Forsmo, 1996
w8* 0/22 (0.0) 1/44 (2.3) 0.65 (0.03 to 15.39)
Bruinsma, 2007
w13 20/1016 (2.0) 41/2293 (1.8) 1.10 (0.65 to 1.87)
Pooled laser ablation 20/1038 (1.0) 42/2337 (2.0) 1.09 (0.64 to 1.83), P=0.749 (I
2=0.0%)
*Study with continuity correction k=0.05.
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spective studies included in this meta-analysis pre-
sented wide variations in the loop sizes used and
consequently the cone volume removed, which
probably explains the wide range of relative risks
(from0.46to7.00)andthenon-significantpooledeffect
of loop excision on perinatal mortality. On the other
hand,thelackofanyadverseeffectswiththeuseoflaser
ablation and cryotherapy might be explained by the
nature of the destruction of tissue that extends at a
rather steady depth, which should be about 5 mm,
631
whereasinloop excisionthe excisionisusuallydeeper
at the centre than at the edges.
32 Others suggested that
pathophysiological mechanisms might also be
mediated by the different composition of the quality
of collagen in the regenerated cervix
33 or other
immunological factors, such as impairment of the
defence mechanisms and alteration of the cervicova-
ginal flora.
34
Alternative explanations
One of the major questions is whether the observed
differences in the frequency of adverse pregnancy
outcomes can be explained by other factors. As
comparison groups (treated for cervical intraepithelial
neoplasia with a particular procedure versus non-
treated) were non-randomised, effects and effect sizes
cannot be attributed with certainty to the treatment
alone.
35Womenwithcervicalintraepithelialneoplasia
are known to have demographic, behavioural, and
sexualcharacteristicsthatincreasetheirriskofadverse
obstetric outcomes. Bacterial vaginosis, for instance, is
associated with premature rupture of membranes and
is found more often in women with cervical intra-
epithelial neoplasia than in the general screening
population.
36-38 In most studies, the reference group
was drawn from the general obstetric population with
partialadjustmentforconfoundingfactorsbymatching
for age, smoking status, parity, etc. One exception was
the study by Bruinsma et al, in which both treated and
non-treated women were drawn from women referred
for assessment of cervical cytological abnormalities
and which showed the lowest relative risk of perinatal
mortalityassociatedwithcoldknifeconisationorlarge
loopexcisionofthetransformationzone(seefig1).
w13 29
As t u d yf r o mN o r w a y
w25 showed that women
exposed to risk factors for cervical intraepithelial
neoplasia are also at risk of serious pregnancy out-
comes. Pregnant women who were subsequently
diagnosed with cervical carcinoma in situ showed a
riskofperinatalmortality,beforecoldknifeconisation,
that was already 21% higher than in women who had
never been treated. Pregnancies after cold knife
conisation were associated with a relative risk of 11.4.
When we accounted for the increased risk before
conisation, the adjusted relative risk for perinatal
mortality was 9.4.
Potential inflation of the relative risks due to the
choice of a reference group, that does not share other
risk factors for adverse pregnancy outcomes, was also
mentioned by Sadler et al.
29 In their study in New
Zealand,treatedwomenandwomeninthenon-treated
comparison group were both recruited from a colpo-
scopy clinic. The resulting relative risk for preterm
delivery associated with large loop excision was 1.30
(0.89to1.88),whichwaslowerthanthepooledrelative
risk.
16 These data indicate that factors other than the
treatment of cervical intraepithelial neoplasia are
contributingtotheriskofpretermdeliveryandstudies
that select their controls from the general population
would therefore be biased in favour of detecting an
effect.
Moreover, women who require treatment for
cervical intraepithelial neoplasia are selected for one
treatment or another on the basis of several important
characteristics that are likely to affect the chance of
subsequent morphological damage to the cervix.
These include size, severity, and site of the lesion,
anatomical characteristics of the transformation zone,
Table 6 |Meta-analysisofstudiescomparingoutcomeofseverelowbirthweight(<1000g)
accordingtotreatmentforcervicalintraepithelialneoplasia
Study
No (%) of women
Relative risk (95% CI) Treated Not treated
Excisional treatment
Cold knife conisation
Lund, 1986
w25 17/251 (6.8) 1/285 (0.4) 19.30 (2.59 to 144.01)
Bruinsma, 2007
w13 2/73 (4.1) 41/2293 (1.8) 1.53 (0.38 to 6.21)
Large loop excision of transformation zone
Bruinsma, 2007
w13* 0/69 (0.0) 41/2293 (1.8) 0.39 (0.02 to 6.35)
Excision (not otherwise specified)
Sjoborg, 2007
w15 11/742 (1.5) 1/742 (0.1) 11.00 (1.42 to 84.99)
Ablative treatment
Diathermy
Bruinsma, 2007
w13 11/773 (1.4) 41/2293 (1.8) 0.80 (0.41 to 1.54)
Laser ablation
Bruinsma, 2007
w13 10/1016 (1.0) 41/2293 (1.8) 0.55 (0.28 to 1.09)
Pooled ablative 21/1789 (1.2) 82/4586 (1.8) 0.67 (0.41 to 1.07),
P=0.448 (I
2=0.0%)
*Study with continuity correction k=0.05.
Table |7 Relativerisk(95%confidenceinterval)forperinatalmortalityinwomentreatedwith
largeloopexcisionoftransformationzoneforcervicalcancerprecursorsversuswomennot
treated.Resultsobtainedwithdifferentmodelsandmethodsforcontinuitycorrectionin
instancesofzerocasesofperinatalmortalityinoneofcomparisongroups
Model
Continuity correction*
1234
Mantel-Haenszel:
Fixed effect 1.21 (0.77 to 1.91) 1.19 (0.74 to 1.89) 1.19 (0.74 to 1.89) 1.20 (0.76 to 1.91)
Random effect 1.18 (0.74 to 1.88) 1.14 (0.70 to 1.84) 1.14 (0.70 to 1.85) 1.20 (0.75 to 1.93)
Inverse variance:
Fixed effect 1.18 (0.74 to 1.88) 1.14 (0.70 to 1.84) 1.14 (0.70 to 1.85) 1.20 (0.75 to 1.93)
Random effect 1.17 (0.74 to 1.87) 1.14 (0.70 to 1.84) 1.14 (0.70 to 1.85) 1.20 (0.75 to 1.93)
Poisson regression
(fixed effect)†
1.18 (0.98 to 1.41)
*1: adding constant k to each cell in 2×2 contingency table (k=0.05); 2: same as (1) with k=0.01; 3: k computed
from reciprocal of size of non-treated group; 4: k computed empirically from studies without zero cases of
perinatal mortality.
†No continuity correction applied.
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disease.
39 In general, ablation is used to treat areas that
are smaller and less severe, whereas excisional treat-
mentsareusedfortheformerindicationbutalsowhen
there is a suspicion of invasion, a larger area, or
transformation zones extending deep in the endo-
cervical canal. This means that there is already an
inherent bias towards removal of larger areas of the
cervix with excisional treatments, which one would
expecttobeassociatedwitha worseobstetricoutcome
in the future.
Although all these factors could explain observed
effects,thefactthatthesizeanddirectionoftherelative
risks were consistent throughout the studies, with
adjustmentforvariousfactors,supportstheconclusion
that cold knife conisation, laser conisation, and radical
diathermy do increase the risk of serious adverse
pregnancy outcomes.
Moreover, study design characteristics and quality
parameters (prospective v retrospective design,
practice v population based selection of patients,
adequacy of control for confounding factors, proce-
dure for matching treated to non-treated patients) did
not explain the heterogeneity between studies (data of
meta-regressionnotshownbutavailablefromauthors).
Implications for practice
Whether there is a critical threshold in the amount of
tissue excised or destroyed that determines obstetric
morbidity and success of treatment in terms of
recurrent cervical intraepithelial neoplasia or cancer
arekeyquestionsthatremaintobeanswered.Havinga
clear understanding of this relation would be useful in
guiding clinical decision making. Three recent studies
have shown that treated women are still at higher risk
thanthegeneralpopulationfordevelopingsubsequent
invasive cervical cancer, even many years after
treatment,
40-42 and some gynaecologists warn that less
aggressive treatments might increase this risk.
43 Evi-
dence indicates that testing for human papillomavirus
Table 8 |Meta-analysisofadverseobstetricoutcomesintreatedwomen(byprocedure)andinnon-treatedcontrolpopulations
withpooledfrequencyofobstetriceventsandnumberneededtotreattoobserveharm(NNTH)
Outcome and procedure No of studies No of events No (%, 95% CI) NNTH
Perinatal mortality
Cold knife conisation 6 13 510 (2.2, 1.5 to 2.9) 71
Laser conisation 3 6 390 (2.3, 0.8 to 3.9) 67
Large loop excision 7 22 3601 (1.0, 1.0 to 1.1) 500
Radical diathermy 1 18 773 (2.3, 2.3 to 2.3) 67
Control 14 6325 1 055 673 (0.8, 0.6 to 1.0) —
Preterm delivery <32/34 weeks
Cold knife conisation 5 18 343 (4.6, 3.0 to 6.1) 30
Laser conisation 1 1 53 (1.9, 1.8 to 2.0) 167
Large loop excision 4 51 3392 (2.0, 1.8 to 2.2) 143
Radical diathermy 1 38 760 (5.0, 5.0 to 5.0) 27
Control 9 10 634 500 440 (1.3, 0.9 to 1.7) —
Preterm delivery <28/30 weeks
Cold knife conisation 3 6 246 (2.5, 1.3 to 3.7) 53
Large loop excision 3 14 2908 (1.0, 0.0 to 2.7) 250
Radical diathermy 1 15 760 (2.0, 2.0 to 2.0) 71
Control 5 3962 473 013 (0.6, 0.1 to 1.0) —
Low birth weight <2000 g
Cold knife conisation 1 7 73 (9.6, 2.8 to 16.3) 16
Laser conisation 1 7 65 (10.8, 3.2 to 18.3) 14
Large loop excision 1 3 69 (4.3, <0.0 to 9.2) 106
Radical diathermy 1 53 773 (6.9, 5.1 to 8.6) 29
Control 4 96 2939 (3.4, 3.0 to 3.8) —
Low birth weight <1500 g
Cold knife conisation 1 3 73 (4.1, <0.0 to 8.7) 36
Laser conisation 1 5 65 (7.7, 1.2 to 14.2) 16
Large loop excision 1 1 69 (1.4, <0.0 to 4.3) 670
Radical diathermy 1 35 773 (4.5, 3.1 to 6.0) 31
Control 4 47 3209 (1.3, 0.5 to 2.2) —
Low birth weight <1000 g
Cold knife conisation 1 2 73 (2.7, <0.0 to 6.5) 54
Large loop excision 1 0 69 (0.0, 0.0 to 0.0) —
Radical diathermy 1 11 773 (1.4, 0.6 to 2.3) 191
Control 2 42 3035 (0.9, <0.0 to 2.6) —
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for cervical intraepithelial neoplasia. In particular,
because of its high negative predictive value, it can
clearly identify those women who are at low risk of
residualorrecurrentdisease,
44-46andthiscouldbeused
toalleviatereservationsaboutshiftingtolessaggressive
treatment practices. Moreover, optimal triage and
diagnostic procedures should be developed that select
only those progressing cases that need aggressive
treatment.
4547 Introduction of prophylactic vaccines
for human papillomavirus will result in a considerable
decrease in the incidence of cervical cancer and
precursor lesions requiring treatment, which will
subsequently reduce the adverse obstetric conse-
quences.
Conclusions
All excisional procedures used to treat cervical intra-
epithelialneoplasiaseemtobeassociatedwithadverse
obstetric morbidity, but among these, only cold knife
conisation is associated with a significantly increased
rate of severe outcomes. The risk of serious obstetric
morbidity associated with large loop excision of the
transformation zone was not significantly different
fromunity,thoughwecannotexcludethepossibilityof
any increased risk. Loop excisions that remove large
amounts of cervical tissue probably have the same
effect as knife cone biopsies. Most loop excisions in
young women with fully visible transformation zones
need to be only 1 cm deep, and this should protect
againstseriousobstetricoutcomes.Giventhedesignof
published observational studies, observed differences
inperinatalmortalityandsevereprematuredeliveryin
treated versus non-treated women cannot be ascribed
solely to treatment. Moreover, the precise conditions
thatdeterminetheoncologicalandreproductivehealth
outcomes are insufficiently known and require further
research. Nevertheless, women of reproductive age
should be informed about the potential impact on
future pregnancies. Gynaecologists should tailor the
management of young woman to minimise possible
adverse obstetric outcomes at the same time as
minimising residual disease rates.
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